dcsimg PHIP
 
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. - B
YOU SHOULD READ THE WARNING IN THE DOCUMENT.
 
WARNING
IMPORTANT
EXPECTED TIMETABLE
CONTENTS
SUMMARY
DEFINITIONS
GLOSSARY OF TECHNICAL TERMS
FORWARD-LOOKING STATEMENTS
RISK FACTORS
WAIVERS FROM STRICT COMPLIANCE WITH THE LISTING RULES AND EXEMPTION FROM STRICT COMPLIANCE WITH THE COMPANIES (WINDING UP AND MISCELLANEOUS PROVISIONS) ORDINANCE
INFORMATION ABOUT THIS DOCUMENT AND THE [REDACTED]
DIRECTORS, SUPERVISORS AND PARTIES INVOLVED IN THE [REDACTED]
CORPORATE INFORMATION
INDUSTRY OVERVIEW
REGULATORY OVERVIEW
HISTORY AND CORPORATE STRUCTURE
BUSINESS
RELATIONSHIP WITH OUR CONTROLLING SHAREHOLDERS
CONNECTED TRANSACTIONS
DIRECTORS, SUPERVISORS AND SENIOR MANAGEMENT
SUBSTANTIAL SHAREHOLDERS
SHARE CAPITAL
FINANCIAL INFORMATION
FUTURE PLANS AND [REDACTED]
[REDACTED]
STRUCTURE OF THE [REDACTED]
HOW TO APPLY FOR [REDACTED]
APPENDIX I - ACCOUNTANTS' REPORT
APPENDIX II - UNAUDITED [REDACTED] FINANCIAL INFORMATION
APPENDIX III - TAXATION AND FOREIGN EXCHANGE
APPENDIX IV - SUMMARY OF PRINCIPAL LAWS AND REGULATIONS
APPENDIX V - SUMMARY OF ARTICLES OF ASSOCIATION
APPENDIX VI - PROPERTY VALUATION REPORT
APPENDIX VII - STATUTORY AND GENERAL INFORMATION
APPENDIX VIII - DOCUMENTS DELIVERED TO THE REGISTRAR OF COMPANIES AND AVAILABLE ON DISPLAY